Draft Guidance for Industry and Staff; Availability: Factors To Consider When Making Benefit-Risk Determinations in Medical Device Premarket Review

Document ID: FDA-2011-D-0577-0001
Document Type: Notice
Agency: Food And Drug Administration
Topics: No Topics associated with this document
Federal Register Number: 2011-20652
View Document:  View as format pdf View as format html

Details Information

Document Subtype: Notice of Availability
Received Date: August 15 2011, at 12:00 AM Eastern Daylight Time
Start-End Page: 50483 - 50484
Page Count: 2
Comment Start Date: August 15 2011, at 12:00 AM Eastern Standard Time
Comment Due Date: November 14 2011, at 11:59 PM Eastern Standard Time

Comments

    View All
Total: 15
Francisco Martinez Murillo - Comment
Posted: 09/27/2011     ID: FDA-2011-D-0577-0003

Nov 14,2011 11:59 PM ET
NeuroPace, Inc. - Comment
Posted: 11/04/2011     ID: FDA-2011-D-0577-0004

Nov 14,2011 11:59 PM ET
Novartis - Comment
Posted: 12/16/2011     ID: FDA-2011-D-0577-0005

Nov 14,2011 11:59 PM ET
Stephanie Bechtold - Comment
Posted: 12/16/2011     ID: FDA-2011-D-0577-0006

Nov 14,2011 11:59 PM ET
Roche Diagnostics - Comment
Posted: 12/16/2011     ID: FDA-2011-D-0577-0007

Nov 14,2011 11:59 PM ET

Related Documents

Total: 0
No documents available.